Connected intelligence (CI) and end-to-end quality are two concepts that, when combined, have a transformative impact on the future of drug development and clinical trials, marking a significant change in how pharmaceutical companies manage the process of bringing new products to market. By combining different technologies and methods to build a smooth, data-focused environment that improves quality, efficiency, […]
Advertisement